Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rosing

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 29, 2014
Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-αM C L G D Thomassen, A C A Heinzmann, L Herfs, et al.
Journal of Thrombosis and Haemostasis : JTH|November 28, 2008
Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden miceS N Tchaikovski, B J M van Vlijmen, A C A Cleuren, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2007
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitorH A A M van Vliet, R M Bertina, A E A Dahm, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual peopleA W F T Toorians, M C L G D Thomassen, S Zweegman, et al.
British Journal of Haematology|April 1, 1997
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptivesJ Rosing, G Tans, G A Nicolaes, et al.
Thrombosis and Haemostasis|August 6, 2000
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptivesJ C Meijers, S Middeldorp, W Tekelenburg, et al.
Thrombosis Research|January 21, 2014
Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptivesM Raps, J Curvers, F M Helmerhorst, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
Determinants of the APTT- and ETP-based APC sensitivity testsM C H de Visser, A van Hylckama Vlieg, G Tans, et al.
Thrombosis and Haemostasis|August 6, 2000
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over studyS Middeldorp, J C Meijers, A E van den Ende, et al.
Lancet (London, England)|January 15, 2000
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over studyJ Rosing, S Middeldorp, J Curvers, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Haemostasis : JTH|October 29, 2014
Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-αM C L G D Thomassen, A C A Heinzmann, L Herfs, et al.
Journal of Thrombosis and Haemostasis : JTH|November 28, 2008
Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden miceS N Tchaikovski, B J M van Vlijmen, A C A Cleuren, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2007
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitorH A A M van Vliet, R M Bertina, A E A Dahm, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual peopleA W F T Toorians, M C L G D Thomassen, S Zweegman, et al.
British Journal of Haematology|April 1, 1997
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptivesJ Rosing, G Tans, G A Nicolaes, et al.
Thrombosis and Haemostasis|August 6, 2000
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptivesJ C Meijers, S Middeldorp, W Tekelenburg, et al.
Thrombosis Research|January 21, 2014
Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptivesM Raps, J Curvers, F M Helmerhorst, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
Determinants of the APTT- and ETP-based APC sensitivity testsM C H de Visser, A van Hylckama Vlieg, G Tans, et al.
Thrombosis and Haemostasis|August 6, 2000
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over studyS Middeldorp, J C Meijers, A E van den Ende, et al.
Lancet (London, England)|January 15, 2000
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over studyJ Rosing, S Middeldorp, J Curvers, et al.
Pageof 15